Skip to main content
Home
language-selector-globe Czech Republic | en
Choose Location
language-selector-globe Czech Republic |
CzechEnglish
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Global | en
Novartis Foundation | en
Sandoz | en
Egypt | en
Israel | he
South Africa | en
Turkey | tr
language-selector-globe Czech Republic
Choose Location
language-selector-globeCzech Republic
CzechEnglish
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Global | en
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis Foundation | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Novartis in the Czech Republic 
      • Strategy 
      • Diversity and inclusion 
      • People and culture 
      • Products 
      • Country leadership team 
      • Our mission and vision 
      • Innovative medicines 
      • Contact 
      Novartis Česká republika About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Our patient portals for Czech Republic 
      • Products 
      • Adverse event reporting 
      • Provision of gifts and grants 
      Babička s vnučkou v objetí Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Products 
      • Novartis pipeline 
      • Adverse event reporting 
      • Novartis clinical trials 
        • Clinical trials in Czech Republic 
      • VPOIS 
      • Expert information 
      Vědec se dívá do mikroskopu Healthcare Professionals
    • Research and development 
      • Research and development in Czech Republic 
      Vědkyně v laboratoři Research and development
    • ESG 
      • Ethics, risk and compliance 
      • Access 
      • Environmental sustainability 
      • Global health 
      • Ethical behavior 
      • Whistleblow line 
      Ruka na rozpukané vyprahlé hlíně ESG
    • News 
      • News archive 
      • Stories 
      • Media library 
      • Media contacts 
      Diskutující lidé s notebooky nad odbornými články News
    • Careers 
      • Career search 
      • Meet the teams 
      • Personal growth 
      • Early talent 
      • How we work 
      • Leadership trainee program 
      • Well-being 
      • Diversity and inclusion 
      • Awards and recognition 
      Usmívající se žena v posluchárně Careers
    • Coronavirus 
      Částice viru SARS CoV 2 na snímku z elektronového mikroskopu. Coronavirus
    Female scientist in laboratory Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort descending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort descending Site Location Division Business Functional Area Date Posted
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Sales Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Sales Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Sales Sep 24, 2024
District Manager Changsha (Hunan Province) China International Innovative Medicines Sales Jun 05, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Sales Sep 24, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
DM Tangshan (Hebei Province) China International Innovative Medicines Sales Apr 14, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
EA & Program Coordinator Beijing (Beijing) China Corporate Affairs Innovative Medicines Communications & Public Affairs Oct 22, 2024
Engineering Lead, RLT CN Jiaxing (Zhejiang Province) China Operations Innovative Medicines Technical Operations Aug 19, 2024
Equipment Engineer Changping County (Beijing) China Operations Innovative Medicines Technical Operations May 21, 2024
Equipment Operator Changping County (Beijing) China Operations Innovative Medicines Technical Operations Jun 13, 2024
Executive Product Specialist Quanzhou (Fujian Province) China International Innovative Medicines Sales Sep 18, 2024
Expert Science & Technology Changshu (Jiangsu Province) China Development Innovative Medicines Research & Development Sep 03, 2024
Expert Science & Technology II- Analytical Research & Development Changshu (Jiangsu Province) China Development Innovative Medicines Research & Development Sep 18, 2024
First Line Manager / District Manager Xiamen (Fujian Province) China International Innovative Medicines Sales Jun 19, 2024
First Line Manager / District Manager Changchun (Jilin Province) China International Innovative Medicines Sales Oct 09, 2024
First Line Manager / District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Sales Oct 09, 2024
Head DPDAI China Shanghai (Shanghai) China Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Oct 14, 2024
Head of Customer Strategy & Operations Shanghai (Shanghai) China International Innovative Medicines Marketing Sep 03, 2024
Head of MA South Guangzhou (Guangdong Province) China International Innovative Medicines Market Access Oct 10, 2024
Manager-Retail National Key Account Changsha (Hunan Province) China International Innovative Medicines Sales Jul 04, 2024
Manufacturing Specialist Changping County (Beijing) China Operations Innovative Medicines Technical Operations Apr 26, 2024
Market Access Specialist Hefei (Anhui Province) China International Innovative Medicines Market Access Sep 03, 2024
Medical Advisor Shanghai (Shanghai) China International Innovative Medicines Research & Development Jul 15, 2024
Medical Advisor Shanghai (Shanghai) China International Innovative Medicines Research & Development Sep 11, 2024
Medical Advisor, HEMA Shanghai (Shanghai) China International Innovative Medicines Research & Development Oct 18, 2024
Medical Advisor, Ophtha Shanghai (Shanghai) China International Innovative Medicines Research & Development Oct 18, 2024
Medical Science Liaison Guangzhou (Guangdong Province) China International Innovative Medicines Research & Development Aug 08, 2024
Medical Science Liaison, Immunology Chongqing (Chongqing Province) China International Innovative Medicines Research & Development Sep 30, 2024
Mgr. DDIT Svc.Mgt China Dalian (Liaoning Province) China Operations CTS Technology Transformation Apr 21, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 15
  • › Next page

Novartis Czech Republic

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
  • Adverse event reporting
Media Center
  • News archive
  • Stories
Our Portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis websites
  • Global
Footer Bottom
© 2024 Novartis s.r.o
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in the Czech Republic